BLIMP-1 mediates extinction of major histocompatibility class II transactivator expression in plasma cells

[1]  K. Calame,et al.  Repression of c-myc Is Necessary but Not Sufficient for Terminal Differentiation of B Lymphocytes In Vitro , 2000, Molecular and Cellular Biology.

[2]  J. Harton,et al.  Class II Transactivator: Mastering the Art of Major Histocompatibility Complex Expression , 2000, Molecular and Cellular Biology.

[3]  K. Calame,et al.  BLIMP-1: trigger for differentiation of myeloid lineage , 2000, Nature Immunology.

[4]  K. Calame,et al.  Transcriptional Repression by Blimp-1 (PRDI-BF1) Involves Recruitment of Histone Deacetylase , 2000, Molecular and Cellular Biology.

[5]  K. Wright,et al.  A Novel Element and a TEF-2-like Element Activate the Major Histocompatibility Complex Class II Transactivator in B-lymphocytes* , 1999, The Journal of Biological Chemistry.

[6]  J. Ting,et al.  Differential selectivity of CIITA promoter activation by IFN-γ and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-α , 1999, Journal of Neuroimmunology.

[7]  J. Platt,et al.  Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. , 1999, Journal of immunology.

[8]  J. Ting,et al.  Two Distinct Gamma Interferon-Inducible Promoters of the Major Histocompatibility Complex Class II Transactivator Gene Are Differentially Regulated by STAT1, Interferon Regulatory Factor 1, and Transforming Growth Factor β , 1999, Molecular and Cellular Biology.

[9]  C. Benoist,et al.  Mice lacking the transcription factor CIITA--a second look. , 1998, International immunology.

[10]  K. Calame,et al.  Evidence that Immunoglobulin VH-DJ Recombination Does Not Require Germ Line Transcription of the Recombining Variable Gene Segment , 1998, Molecular and Cellular Biology.

[11]  I. Weissman,et al.  Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers. , 1998, Immunity.

[12]  J. Ting,et al.  Identification of Distinct Regions of 5′ Flanking DNA That Mediate Constitutive, IFN-γ, STAT1, and TGF-β-Regulated Expression of the Class II Transactivator Gene , 1998, The Journal of Immunology.

[13]  G. Li,et al.  The DMB promoter: delineation, in vivo footprint, trans-activation, and trans-dominant suppression. , 1997, Journal of Immunology.

[14]  B. Mach,et al.  Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA , 1997, The EMBO journal.

[15]  K. Calame,et al.  Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. , 1997, Science.

[16]  R. Ransohoff,et al.  TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. , 1997, Journal of immunology.

[17]  N. Reiner,et al.  TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-gamma action. , 1997, Journal of immunology.

[18]  R. Accolla,et al.  Active suppression of the class II transactivator‐encoding AIR‐1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells , 1996, European journal of immunology.

[19]  I. Wilson.  Another Twist to MHC-Peptide Recognition , 1996, Science.

[20]  R. Flavell,et al.  Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. , 1996, Immunity.

[21]  Partho Ghosh,et al.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.

[22]  D. Weber,et al.  DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. , 1995, Immunity.

[23]  P. Cresswell,et al.  HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.

[24]  G. Stark,et al.  Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. , 1994, Immunity.

[25]  Y. Natkunam,et al.  Simultaneous activation of Ig and Oct-2 synthesis and reduction of surface MHC class II expression by IL-6. , 1994, Journal of immunology.

[26]  R. Flavell,et al.  Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes , 1994, The Journal of experimental medicine.

[27]  W. Reith,et al.  Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA , 1994, The Journal of experimental medicine.

[28]  Mark M. Davis,et al.  Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells , 1994, Cell.

[29]  B. Arp,et al.  HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells , 1994, Nature.

[30]  K. Wright,et al.  Human major histocompatibility complex class II-associated invariant chain gene promoter. Functional analysis and in vivo protein/DNA interactions of constitutive and IFN-gamma-induced expression. , 1993, The Journal of biological chemistry.

[31]  B. Mach,et al.  Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome) , 1993, Cell.

[32]  T Friedmann,et al.  Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Taniguchi,et al.  Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system , 1993, Molecular and cellular biology.

[34]  J. Ting,et al.  Regulation of MHC gene expression. , 1993, Current opinion in immunology.

[35]  L. Glimcher,et al.  Promoter accessibility within the environment of the MHC is affected in class II‐deficient combined immunodeficiency. , 1993, The EMBO journal.

[36]  R. Flavell,et al.  Reactivation of a major histocompatibility complex class II gene in mouse plasmacytoma cells and mouse T cells , 1992, The Journal of experimental medicine.

[37]  S. Nishikawa,et al.  Role of I-A molecules in early stages of B cell maturation. , 1992, Journal of Immunology.

[38]  T. Maniatis,et al.  Identification and characterization of a novel repressor of beta-interferon gene expression. , 1991, Genes & development.

[39]  M. Cooper,et al.  Regulated expression of cell surface antigens during B cell development. , 1990, Seminars in immunology.

[40]  K. Calame,et al.  A transcriptional repressor of c-myc , 1989, Nature.

[41]  P. Dellabona,et al.  Transcriptional control of MHC class II gene expression during differentiation from B cells to plasma cells. , 1989, Journal of immunology.

[42]  J. Strominger,et al.  Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[43]  K. Calame,et al.  A plasmacytoma-specific factor binds the c-myc promoter region. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  W. Fiers,et al.  Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Hatat,et al.  Differential regulation of HLA‐DR mRNAs and cell surface antigens by interferon. , 1983, The EMBO journal.

[46]  C. Y. Wang,et al.  Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development. , 1978, Journal of immunology.

[47]  F. Melchers,et al.  Inhibition of mitogenic stimulation of mouse lymphocytes by anti‐mouse immunoglobulin antibodies. I. Mode of action , 1974, European journal of immunology.

[48]  Tae Hoon Kim,et al.  PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. , 1999, Genes & development.

[49]  Anthony Maxwell,et al.  Mode of Action , 1998 .

[50]  J. Longmire,et al.  Isolation of a B-cell-specific promoter for the human class II transactivator , 1997, Immunogenetics.

[51]  L. Glimcher,et al.  Sequences and factors: a guide to MHC class-II transcription. , 1992, Annual review of immunology.

[52]  C. Benoist,et al.  Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. , 1990, Annual review of immunology.

[53]  G. Nossal,et al.  Maturation of B lymphocytes. I. Concurrent appearance of increasing Ig, Ia, and mitogen responsiveness. , 1979, Journal of immunology.